France (FR)

close-button

Project Types

Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third party funded individual grant
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project

Status

Project year

From
To
Scaling up Local physical Activity policy monitoRinG initiativEs (LARGE) (LARGE) Jan. 1, 2024 - Dec. 31, 2024 Clinical traslatio of FLASHKNiFE, a promising device for ultrahigh dose-rate radiation therapy (FLASHKNiFE) (ST-EUC-EIT-09_FLASHKNiFE 2024) Jan. 1, 2024 - Dec. 31, 2024 Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. (NeutroCure) Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. Jan. 1, 2020 - Dec. 31, 2024 Vorbereitung eines EU HORIZON Projekts zu Lagerstätten kritischer Metalle (LAKRIMET) Nov. 1, 2023 - Nov. 30, 2024 Action for Research and Teaching Mining exploration Inclusive School (ARTeMIS) Action for Research and Teaching Mining exploration Inclusive School Nov. 1, 2021 - Oct. 31, 2024 Boost Of Organic Solar Technology for European Radiance (BOOSTER) Boost Of Organic Solar Technology for European Radiance Sept. 1, 2020 - Aug. 31, 2024 Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response (ONCOBIOME) Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response Jan. 1, 2019 - June 30, 2024 SmartHome automation for seniors using simple DIY solutions (SmartHome4Seniors) SmartHome automation for seniors using simple DIY solutions Dec. 1, 2021 - May 31, 2024 EELISA INNOvation and COmmon REsearch strategy (EELISA innoCORE) EELISA INNOvation and COmmon REsearch strategy June 1, 2021 - May 31, 2024 Validating DIGItal biomarkers for better personalized treatment of Parkinson's Disease (DIGIPD) May 1, 2021 - April 30, 2024